Alcohol Addiction - Pipeline Review, H2 2018

Publisher Name :
Date: 10-Jul-2018
No. of pages: 151
Inquire Before Buying

Alcohol Addiction - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alcohol Addiction - Pipeline Review, H2 2018, provides an overview of the Alcohol Addiction (Central Nervous System) pipeline landscape.

Alcohol addiction refers to a psychological and physical dependency on alcohol. Symptoms include decreased involvement in extracurricular activities, depression, restlessness, inability to control drinking and violent behavior. Risk factors include age, family history and depression and other mental health problems.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Alcohol Addiction - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Alcohol Addiction (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Alcohol Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Alcohol Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 2, 11, 5, 1, 20 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 5 molecules, respectively.

Alcohol Addiction (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Alcohol Addiction (Central Nervous System).

- The pipeline guide reviews pipeline therapeutics for Alcohol Addiction (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Alcohol Addiction (Central Nervous System) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Alcohol Addiction (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Alcohol Addiction (Central Nervous System)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Alcohol Addiction (Central Nervous System).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Alcohol Addiction (Central Nervous System) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Alcohol Addiction - Pipeline Review, H2 2018

Table of Contents
Table of Contents 2
Introduction 5
Alcohol Addiction - Overview 6
Alcohol Addiction - Therapeutics Development 7
Alcohol Addiction - Therapeutics Assessment 16
Alcohol Addiction - Companies Involved in Therapeutics Development 28
Alcohol Addiction - Drug Profiles 41
Alcohol Addiction - Dormant Projects 133
Alcohol Addiction - Discontinued Products 136
Alcohol Addiction - Product Development Milestones 137
Appendix 145

List of Tables
Number of Products under Development for Alcohol Addiction, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Companies, H2 2018 (Contd..1), H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Companies, H2 2018 (Contd..1), H2 2018
Products under Development by Companies, H2 2018 (Contd..2), H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Target, H2 2018 (Contd..1), H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018 (Contd..1), H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Alcohol Addiction - Pipeline by AbbVie Inc, H2 2018
Alcohol Addiction - Pipeline by Addex Therapeutics Ltd, H2 2018
Alcohol Addiction - Pipeline by Adial Pharmaceuticals LLC, H2 2018
Alcohol Addiction - Pipeline by Arbor Pharmaceuticals LLC, H2 2018
Alcohol Addiction - Pipeline by AstraZeneca Plc, H2 2018
Alcohol Addiction - Pipeline by BioCorRx Inc, H2 2018
Alcohol Addiction - Pipeline by Bionex Pharmaceuticals LLC, H2 2018
Alcohol Addiction - Pipeline by Bioprojet SCR, H2 2018
Alcohol Addiction - Pipeline by Chronos Therapeutics Ltd, H2 2018
Alcohol Addiction - Pipeline by Corcept Therapeutics Inc, H2 2018
Alcohol Addiction - Pipeline by Curemark LLC, H2 2018
Alcohol Addiction - Pipeline by Eli Lilly and Co, H2 2018
Alcohol Addiction - Pipeline by Ethypharm SA, H2 2018
Alcohol Addiction - Pipeline by H. Lundbeck AS, H2 2018
Alcohol Addiction - Pipeline by Heptares Therapeutics Ltd, H2 2018
Alcohol Addiction - Pipeline by Indivior Plc, H2 2018
Alcohol Addiction - Pipeline by Johnson & Johnson, H2 2018
Alcohol Addiction - Pipeline by Kinnov Therapeutics SAS, H2 2018
Alcohol Addiction - Pipeline by Kyorin Pharmaceutical Co Ltd, H2 2018
Alcohol Addiction - Pipeline by Lohocla Research Corp, H2 2018
Alcohol Addiction - Pipeline by Mapreg SAS, H2 2018
Alcohol Addiction - Pipeline by Montisera Ltd, H2 2018
Alcohol Addiction - Pipeline by Omeros Corp, H2 2018
Alcohol Addiction - Pipeline by Opiant Pharmaceuticals Inc, H2 2018
Alcohol Addiction - Pipeline by Pfizer Inc, H2 2018
Alcohol Addiction - Pipeline by Silence Therapeutics Plc, H2 2018
Alcohol Addiction - Pipeline by SK Biopharmaceuticals Co Ltd, H2 2018
Alcohol Addiction - Pipeline by Syntropharma Ltd, H2 2018
Alcohol Addiction - Pipeline by Tonix Pharmaceuticals Holding Corp, H2 2018
Alcohol Addiction - Pipeline by Zynerba Pharmaceuticals Inc, H2 2018
Alcohol Addiction - Dormant Projects, H2 2018
Alcohol Addiction - Dormant Projects, H2 2018 (Contd..1), H2 2018
Alcohol Addiction - Dormant Projects, H2 2018 (Contd..2), H2 2018
Alcohol Addiction - Discontinued Products, H2 2018

List of Figures
Number of Products under Development for Alcohol Addiction, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products by Top 10 Targets, H2 2018
Number of Products by Stage and Top 10 Targets, H2 2018
Number of Products by Top 10 Mechanism of Actions, H2 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018
Number of Products by Routes of Administration, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Molecule Types, H2 2018
Number of Products by Stage and Molecule Types, H2 2018
  • Alzheimer's Disease - Pipeline Review, H2 2018
    Published: 07-Aug-2018        Price: US 2500 Onwards        Pages: 1333
    Alzheimer's Disease - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alzheimer's Disease - Pipeline Review, H2 2018, provides an overview of the Alzheimer's Disease (Central Nervous System) pipeline landscape. Alzheimer's disease is a progressive, degenerative condition causing damage to the memory and behavior due to the attack on the neurons. These neurons are responsible for the synthe......
  • Global and Chinese CNS Disorders Drug Industry, 2018 Market Research Report
    Published: 23-Jul-2018        Price: US 3000 Onwards        Pages: 141
    The 'Global and Chinese CNS Disorders Drug Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global CNS Disorders Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the CNS Disorders Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including ......
  • Amyotrophic Lateral Sclerosis: Epidemiology Forecast to 2027
    Published: 18-Jul-2018        Price: US 3995 Onwards        Pages: 32
    Amyotrophic Lateral Sclerosis: Epidemiology Forecast to 2027 Summary ALS is a rare but fatal progressive neurodegenerative disease that affects the nerve cells in the brain and the spinal cord (Doi et al., 2014). ALS is often referred to as "Lou Gehrig's Disease" after the famous baseball player. ALS severely impacts physical functioning, and initially presents with muscle twitching, weakness in an arm or leg, or sometimes with slurring of speech. Eventually, people......
  • Fatigue - Pipeline Review, H2 2018
    Published: 10-Jul-2018        Price: US 2000 Onwards        Pages: 38
    Fatigue - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fatigue - Pipeline Review, H2 2018, provides an overview of the Fatigue (Central Nervous System) pipeline landscape. Fatigue also referred to as tiredness, exhaustion, lethargy, listlessness, and describes a physical and/or mental state of being tired and weak. Signs and symptoms include aching or sore muscles, painful lymph nodes, ......
  • Fibromyalgia - Pipeline Review, H2 2018
    Published: 10-Jul-2018        Price: US 2000 Onwards        Pages: 76
    Fibromyalgia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fibromyalgia - Pipeline Review, H2 2018, provides an overview of the Fibromyalgia (Central Nervous System) pipeline landscape. Fibromyalgia is a disorder characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory and mood issues. Symptoms include fatigue, depression, headaches, and pain or cramping i......
  • Traumatic Brain Injury - Pipeline Review, H2 2018
    Published: 10-Jul-2018        Price: US 2000 Onwards        Pages: 306
    Traumatic Brain Injury - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury - Pipeline Review, H2 2018, provides an overview of the Traumatic Brain Injury (Central Nervous System) pipeline landscape. Traumatic brain injury happens when an external mechanical force causes brain damage. Traumatic brain injury usually results from a violent blow or jolt to the head or body......
  • Restless Legs Syndrome - Pipeline Review, H2 2018
    Published: 10-Jul-2018        Price: US 2000 Onwards        Pages: 43
    Restless Legs Syndrome - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restless Legs Syndrome - Pipeline Review, H2 2018, provides an overview of the Restless Legs Syndrome (Central Nervous System) pipeline landscape. Restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED), is a disorder of the part of the nervous system that affects the legs and causes an urge to move the......
  • Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2018
    Published: 10-Jul-2018        Price: US 2000 Onwards        Pages: 129
    Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2018, provides an overview of the Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) pipeline landscape. Post-traumatic stress disorder (PTSD) is a mental health condition that's triggered by a terrifying event either experiencing i......
  • Post-Operative Pain - Pipeline Review, H2 2018
    Published: 10-Jul-2018        Price: US 2000 Onwards        Pages: 232
    Post-Operative Pain - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post-Operative Pain - Pipeline Review, H2 2018, provides an overview of the Post-Operative Pain (Central Nervous System) pipeline landscape. Pain is one of the main postoperative adverse outcomes causing distress to patients. Degree of postoperative pain experienced by individuals varies. Cause of pain includes periphera......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs